INDmoney
Dr Reddys Share Price
₹1240.20
+4.80
(+0.39%)
as on
Dr Reddys Stock Performance
as on February 4, 2026 at 4:01 pm IST
Day's Low
Day's High
₹1,230.10₹1,248.30
0.81%
Downside
0.65%
Upside
52 Week's Low
52 Week's High
₹1,020.00₹1,379.7017.76%
Downside
11.25%
Upside
Dr Reddys share price movements today
- Previous Close
- ₹1,235.40
- Open
- ₹1,235.50
- Volume
- 9.48L
- Upper Circuit
- ₹1,358.90
- Lower Circuit
- ₹1,111.90
- Day's Low - High
- ₹1,230.10 - ₹1,248.30
- 52 Week Low - High
- ₹1,020.00 - ₹1,379.70
Dr Reddys Historical Returns
- 1 Month Return
- -1.17 %
- 3 Month Return
- + 2.95 %
- 1 Year Return
- + 1.27 %
- 3 Year Return
- + 42.01 %
- 5 Year Return
- + 32.33 %
Dr Reddys Fundamentals
as on February 4, 2026 at 4:01 pm IST
Market Cap
₹1,03,110.23 Cr
Return on Equity (ROE)
20.15
PE Ratio (TTM)
18.47
Return on capital employed (ROCE)
25.47
Industry PE ratio
39.87
Beta (LTM)
0.86
P/B Ratio
3.31
Dividend Yield
0.7
PEG Ratio
7.81
Quarterly Earnings Growth YOY
-15.28
EPS (TTM)
68.65
Sector
Pharmaceuticals
Book Value
402.27
Technical Analysis
Bullish
View Technical Analysis
Dr Reddys Stock Valuation
as on February 4, 2026 at 4:01 pm IST
Dr Reddys in the last 5 years
Lowest (3.37x)
October 27, 2019
Today (18.47x)
February 3, 2026
Industry (39.87x)
February 3, 2026
Highest (53.88x)
December 18, 2020
Today’s Price to Earnings Ratio: 18.47x
Dr Reddys Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Dr Reddys with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 1,03,110.23 | 6.47% | 0.57 | 5,725 | 32,643 | |
| HOLD | 1,64,829.44 | 13.75% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,36,921.49 | 40.35% | 0.66 | 1,911 | 11,516 | |
| BUY | 60,346.40 | -1.83% | 0.78 | 1,429 | 15,261 | |
| HOLD | 31,232.87 | -2.26% | 0.53 | 698 | 5,616 |
Analyst Recommendation on Dr Reddys Stock
Based on 39 analysts
41.03%
Buy
25.64%
Hold
33.33%
Sell
Based on 39 analysts, 41.03% of analysts recommend a 'HOLD' rating for Dr Reddys. Average target price of ₹1308.98
Source: S&P Global Market Intelligence
Dr Reddys Share Price Target
Get share price movements and forecasts by analysts on Dr Reddys.
What analysts predicted
5.96%UPSIDE
Target Price
₹1308.98
Current Price
₹1240.2
Analyzed by
39 Analysts
High
₹1615
Target
₹1308.98
Low
₹1024
Dr Reddys target price ₹1308.98, a slight upside of 5.96% compared to current price of ₹1240.2. According to 39 analysts rating.
Source: S&P Global Market Intelligence
Dr Reddys Stock’s Investor Sentiment and Interest
Investment in Dr Reddys Laboratories Ltd Shares on INDmoney has grown by 146.28% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:146.28% versus previous 30 day period
Search interest for Dr Reddys Laboratories Ltd Stock has increased by 145% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:145% versus previous 30 day period
Dr Reddys Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Dr Reddys Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Dr Reddys Laboratories Ltd Cash Flow
Figures in Rupees Crores
Dr Reddys Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Dr Reddys Stock
Check out the Mutual Funds with significant holdings in Dr Reddys.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 Parag Parikh Flexi Cap Direct Growth | 1.25% | 13125545 | |
 ICICI Prudential Value Fund Direct Plan Growth | 2.46% | 11845856 | |
 Nippon India Large Cap Fund - Direct Plan - Growth Plan | 1.34% | 5357429 | |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 7.82% | 3973068 | |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 6.02% | 3916074 |
Dr Reddys Corporate Actions
View detailed summary of the earnings and dividend history of Dr Reddys.
Dr Reddys Laboratories Ltd Earnings Results
Dr Reddys Laboratories Ltd’s net profit fell -14.42% since last year same period to ₹1,209.90Cr in the Q3 2025-2026. On a quarterly growth basis, Dr Reddys Laboratories Ltd has generated -10.18% fall in its net profits since last 3-months.
Read More about Earnings ResultsDr Reddys Laboratories Ltd Dividends May,2025
In the quarter ending March 2025, Dr Reddys Laboratories Ltd has declared dividend of ₹8.00 per share on 09 May 2025 - translating a dividend yield of 0.65%.
Read More about Dividends
Indices Featuring Dr Reddys Stock
Check stock indices that include Dr Reddys.
Insights on Dr Reddys Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, DRREDDY stock has moved up by 3.0%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 13.31% to 13.87% in Dec 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 26.64% of holdings in Dec 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 9.61% to 9.47% in Dec 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 1.59K Cr → 1.20K Cr (in ₹), with an average decrease of 8.7% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 9.15K Cr → 9.02K Cr (in ₹), with an average decrease of 1.5% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 24.69% to 22.34% in Dec 2025 quarter
Dr Reddys Stock Futures & Options Contracts
View the latest movement in Dr Reddys Futures & Options, including strike prices, expiry dates, and percentage changes.
Dr Reddys Options
Dr Reddys Futures
About Dr Reddys Laboratories Ltd
Dr Reddy's Laboratories Ltd has a diverse portfolio of products and services, including prescription drugs, generic drugs, over-the-counter drugs, active pharmaceutical ingredients, biotechnology products, and nutraceuticals. Its most popular products include antibiotics, anti-infectives, anti-diabetics, anti-cancer, cardiovascular, gastrointestinal, and dermatology products. Some of its popular brands include Omez, Ciprocin, and Revital. It also has a strong presence in the generics market with its brands such as Reditux and Reditux-D.
Revenue: ₹8,727.00Cr as on December 2025 (Q3 FY26)
Net Profit: ₹1,189.60Cr as on December 2025 (Q3 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: K Satish Reddy
| Organisation | Dr Reddys Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | K Satish Reddy |
| E-voting on shares | Click here to vote |
FAQs
What is Dr Reddys share price today?
Dr Reddys share price today stands at ₹1240.2 as on at the close of the market. Dr Reddys share today touched a day high of ₹1248.3 and a low of ₹1230.1.
What is the 52 week high and 52 week low range for Dr Reddys share?
Dr Reddys touched a 52 week high of ₹1379.7 and a 52 week low of ₹1020. Dr Reddys share price today i.e. is closed at ₹1240.2, which is -10.11% down from its 52 week high and 21.59% up from its 52 week low.
What is Dr Reddys's market capitalisation today?
Dr Reddys market capitalisation is ₹1,03,110.23 Cr as on .
How to buy Dr Reddys shares?
To buy Dr Reddys shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for DRREDDY or Dr Reddys Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Dr Reddys shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Dr Reddys trading volume today?
Dr Reddys trading volume is 9.48L as on . This means that 9.48L shares of Dr Reddys were bought and sold on the stock market during today's trading session.